Allergan (AGN) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 16.4 | 0.93 | -10.1 | 84.4 | 46.3 | 6.22 | ||
| Changes by years, y/y, % | -60% | -94% | -1 189% | -933% | -45% | +2.7% | |||
Allergan. EV/EBITDA
Allergan. EV/EBITDA, changes, %
Allergan (AGN) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2019Q1 | FY2019Q2 | FY2019Q3 | FY2019Q4 | FY2020Q1 | LTM ? | |||
| EV/EBITDA | ? | -20.6 | -8.77 | -21.7 | 46.1 | 27.8 | 6.22 | |
| Changes by years, y/y, % | -313% | -221% | -953% | -44% | -235% | |||
| Changes by quarters, q/q, % | -125% | -57% | +147% | -313% | -40% | |||